Free Trial

Enovix (NASDAQ:ENVX) Announces Q3 2026 Earnings Guidance

Enovix logo with Industrials background
Image from MarketBeat Media, LLC.

Key Points

  • Enovix guided for Q3 2026 EPS of -$0.14, better than the consensus estimate of -$0.16, and projected revenue of $11.0 million versus the $9.5 million consensus.
  • The company’s prior quarter exceeded expectations, reporting EPS of -$0.13 and revenue of $9.02 million, with revenue increasing 20.8% year over year.
  • Analyst sentiment is mixed but leans positive: Enovix has a consensus “Moderate Buy” rating and an average price target of $11.77, while the stock recently traded near its 52-week low at $2.46.
  • Five stocks we like better than Enovix.

Enovix (NASDAQ:ENVX - Get Free Report) issued an update on its third quarter 2026 earnings guidance on Monday morning. The company provided earnings per share (EPS) guidance of -0.140--0.140 for the period, compared to the consensus EPS estimate of -0.160. The company issued revenue guidance of $11.0 million, compared to the consensus revenue estimate of $9.5 million.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on ENVX shares. TD Cowen raised shares of Enovix to a "hold" rating in a research note on Monday, October 5th. Weiss Ratings reiterated a "sell (e+)" rating on shares of Enovix in a report on Friday, October 2nd. Wall Street Zen raised shares of Enovix from a "strong sell" rating to a "sell" rating in a research report on Sunday. B. Riley Financial decreased their price objective on shares of Enovix from $10.00 to $9.00 and set a "buy" rating for the company in a research report on Thursday, August 13th. Finally, Loop Capital upgraded Enovix to a "strong-buy" rating in a research note on Monday, August 17th. One research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, three have issued a Hold rating and two have issued a Sell rating to the company's stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $11.77.

View Our Latest Research Report on Enovix

Enovix Price Performance

ENVX stock opened at $2.46 on Monday. The stock's 50 day moving average is $3.36 and its two-hundred day moving average is $5.11. Enovix has a 52-week low of $2.40 and a 52-week high of $14.21. The company has a market capitalization of $539.85 million, a PE ratio of -3.04 and a beta of 2.49. The company has a quick ratio of 9.37, a current ratio of 9.71 and a debt-to-equity ratio of 2.46.

Enovix (NASDAQ:ENVX - Get Free Report) last released its earnings results on Wednesday, August 12th. The company reported ($0.13) EPS for the quarter, beating the consensus estimate of ($0.15) by $0.02. Enovix had a negative return on equity of 64.50% and a negative net margin of 473.89%. The company had revenue of $9.02 million during the quarter, compared to analysts' expectations of $8.43 million. During the same period in the prior year, the business posted ($0.13) EPS. The business's revenue was up 20.8% on a year-over-year basis. Enovix has set its Q3 2026 guidance at -0.170--0.130 EPS. Analysts predict that Enovix will post -0.80 earnings per share for the current fiscal year.

About Enovix

(Get Free Report)

Enovix Corporation is a battery technology company developing lithium-ion batteries that use a silicon-based anode and a three-dimensional cell architecture. The company's design is intended to increase energy density while incorporating structural features designed to improve safety and cycle life compared with conventional lithium-ion batteries.

Enovix is focused initially on batteries for consumer electronics, including smartphones, wearable devices and other mobile products. It has also identified applications in industrial, medical, aerospace, defense and electric vehicle markets.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Enovix Right Now?

Before you consider Enovix, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Enovix wasn't on the list.

While Enovix currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own in Fall 2026 Cover

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines